Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.74 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.64 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | CRHBP | P24387 | 1/20 | 0.62 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.62 |
| ▸ | FNTA | P49354 | 3/20 | 0.57 |
| ▸ | FNTB | P49356 | 3/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CCR1 | P32246 | 1/20 | 0.54 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18095164 | 1.00 | L3MBTL1 (0.74) | L3MBTL1TAS1R3TAS1R1KMT2AMEN1 | |
| SCHEMBL27974663 | 0.89 | L3MBTL1 (0.63) | L3MBTL1TAS1R3TAS1R1KMT2AMEN1 | |
| SCHEMBL2330865 | 0.89 | L3MBTL1 (0.63) | L3MBTL1TAS1R3TAS1R1KMT2AMEN1 | |
| SCHEMBL9461939 | 0.87 | CA2 (0.69) | KMT2AMEN1ALDH1A1CRHBPCRHR2 | |
| SCHEMBL1158031 | 0.87 | CA2 (0.69) | KMT2AMEN1ALDH1A1CRHBPCRHR2 | |
| SCHEMBL1158033 | 0.87 | CA2 (0.69) | KMT2AMEN1ALDH1A1CRHBPCRHR2 | |
| SCHEMBL13525007 | 0.87 | L3MBTL1 (0.71) | L3MBTL1TAS1R3TAS1R1KMT2AALDH1A1 | |
| SCHEMBL2327433 | 0.87 | L3MBTL1 (0.60) | L3MBTL1TAS1R3TAS1R1KMT2AMEN1 | |
| SCHEMBL27974764 | 0.87 | L3MBTL1 (0.60) | L3MBTL1TAS1R3TAS1R1KMT2AMEN1 | |
| SCHEMBL8106910 | 0.86 | L3MBTL1 (0.74) | L3MBTL1TAS1R3TAS1R1KMT2AFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180070612-A1 | RUMEN BY-PASS ANIMAL FEED COMPOSITION AND METHOD OF MAKING SAME | WAN FENG (US) | 2018-03-15 | — | — | US | claimed |
| EP-3273795-A1 | RUMEN BY-PASS ANIMAL FEED COMPOSITION AND METHOD OF MAKING SAME | Benemilk Oy (FI) | 2018-01-31 | — | — | EP | claimed |
| WO-2016154574-A1 | RUMEN BY-PASS ANIMAL FEED COMPOSITION AND METHOD OF MAKING SAME | BENEMILK OY (FI) | 2016-09-29 | — | — | WO | claimed |
| US-20180070612-A1 | RUMEN BY-PASS ANIMAL FEED COMPOSITION AND METHOD OF MAKING SAME | WAN FENG (US) | 2018-03-15 | — | — | US | disclosed |
| EP-3273795-A1 | RUMEN BY-PASS ANIMAL FEED COMPOSITION AND METHOD OF MAKING SAME | Benemilk Oy (FI) | 2018-01-31 | — | — | EP | disclosed |
| EP-2356979-B1 | ANTI-WRINKLE AGENTS | POLA CHEM IND INC (JP) | 2017-10-25 | — | — | EP | disclosed |
| EP-3173063-A1 | ANTI-WRINKLE AGENTS | Pola Chemical Industries Inc. (JP) | 2017-05-31 | — | — | EP | disclosed |
| WO-2016154574-A1 | RUMEN BY-PASS ANIMAL FEED COMPOSITION AND METHOD OF MAKING SAME | BENEMILK OY (FI) | 2016-09-29 | — | — | WO | disclosed |
| US-8835498-B2 | Anti-wrinkle agents | POLA CHEMICAL INDUSTRIES INC. (JP) | 2014-09-16 | — | — | US | disclosed |
| US-20110245343-A1 | ANTI-WRINKLE AGENTS | POLA CHEMICAL INDUSTRIES INC. (JP) | 2011-10-06 | — | — | US | disclosed |
| EP-2356979-A1 | ANTI-WRINKLE AGENTS | Pola Chemical Industries Inc. (JP) | 2011-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245343-A1 | ANTI-WRINKLE AGENTS | GLA, H1-4, H1-3 | L3MBTL1 1901/4885TAS1R3 746/4885TAS1R1 809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.